EFDID: 501189EFD: View Filing

Issuer: Cancer IQ Inc. (0001810038) - D

Accession: 0001810038-23-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001810038
  • Entity Name:
    Cancer IQ Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    515 N. STATE STREET
    SUITE 1025
    CHICAGO, IL 60654
  • Persons:
    Related Persons 5
    Olufeyikemi Olopade Ayodele
    Executive Officer, Director
    Mark Bakken
    Director
    Joel Krikston
    Director
    Haibo Lu
    Executive Officer, Director
    Carladenise Edwards
    Director
EDGAR: Offering Information
  • Accession Date:
    11/13/2023
  • First Sale Date:
    11/01/2023
  • Offering Amount:
    $6,000,000
  • Amount Sold:
    $3,350,000
  • Amount Remaining:
    $2,650,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Debt
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, MI, NJ, WI
Inactive:IL
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Cancer IQ Inc./s/ Feyi Olopade AyodeleFeyi Olopade AyodeleChief Executive Officer2023-11-10